REAL STORIES. REAL WORKERS. REAL STRENGTH.
Latest Stories
Mesabi Metallics announced plans to invest $15 billion in a new steel mill in Lee County, Iowa, aiming to start production by 2030 with an initial output of 7.5 million tons annually, creating 1,750 permanent jobs and thousands of construction jobs.
In 2025, new FAA A&P mechanic certifications reached record levels, indicating positive strides in addressing the growing workforce gap in the aerospace industry. Despite this progress, the industry still grapples with the challenge of meeting demand amidst increasing retirements, highlighting the ongoing need for skilled workers in American aviation.
Made Scientific has expanded its presence in the US by acquiring an 85,000ft² cell therapy manufacturing facility in Pennsylvania from National Resilience. This acquisition highlights the company’s commitment to investing in American industry and bolstering its production capabilities in the pharmaceutical sector.
Ford Motor Company announced a $1 billion investment to build a new state-of-the-art paint shop at its Kentucky Truck Plant in Louisville. The project will modernize the facility, supporting production of Super Duty trucks and large SUVs, and reinforce Ford’s commitment to U.S. manufacturing.
GE Appliances is investing $1 billion in its Louisville Appliance Park to move dryer production from Mexico to Kentucky, modernize facilities, and secure thousands of U.S. manufacturing jobs.
Market intelligence firm CRU forecasts that as many as nine new lithium mines may start operating in the U.S. by 2030, potentially increasing domestic lithium supply significantly to support clean energy demands and supply chain resilience.
The Department of Transportation has allocated $481 million in grants for airport rehabilitation work through the Federal Aviation Administration’s Airport Infrastructure Grants program. This funding will support crucial infrastructure improvements that benefit American industry and travelers alike.
AbbVie’s new myeloma drug, etentamig, shows promise with a better side effect profile compared to competitors like J&J, Pfizer, and Regeneron. This development could have implications for American pharma industry competitiveness and potentially impact the future of myeloma treatment.
Gossamer Bio has secured a private placement agreement worth up to $250 million, with $150 million committed to advancing the development and potential FDA approval of seralutinib. This funding announcement could have implications for American pharmaceutical innovation and the future availability of new treatments in the industry.
The new Shipbuilding Advanced Institute for Learning (SAIL) will expand workforce training space and aims to prepare about 3,000 new hires per year for submarine construction at Electric Boat’s Quonset Point shipyard.
Top Stories
